These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

723 related items for PubMed ID: 10736241

  • 1. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.
    Feng Q, Liu Y, Liu K, Byrne S, Liu G, Wang X, Li Z, Ockleford CD.
    Placenta; 2000; 21(2-3):184-93. PubMed ID: 10736241
    [Abstract] [Full Text] [Related]

  • 2. Plasminogen activators and inhibitors are transcribed during early macaque implantation.
    Feng Q, Liu K, Liu YX, Byrne S, Ockleford CD.
    Placenta; 2001; 22(2-3):186-99. PubMed ID: 11170823
    [Abstract] [Full Text] [Related]

  • 3. Expression and function of the urokinase type plasminogen activator during mouse hemochorial placental development.
    Teesalu T, Blasi F, Talarico D.
    Dev Dyn; 1998 Sep; 213(1):27-38. PubMed ID: 9733098
    [Abstract] [Full Text] [Related]

  • 4. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

  • 5. Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.
    Hu ZY, Liu YX, Liu K, Byrne S, Ny T, Feng Q, Ockleford CD.
    J Anat; 1999 Feb; 194 ( Pt 2)(Pt 2):183-95. PubMed ID: 10337950
    [Abstract] [Full Text] [Related]

  • 6. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
    Nordengren J, Pilka R, Noskova V, Ehinger A, Domanski H, Andersson C, Høyer-Hansen G, Hansson SR, Casslén B.
    Mol Hum Reprod; 2004 Sep; 10(9):655-63. PubMed ID: 15243126
    [Abstract] [Full Text] [Related]

  • 7. Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas.
    Foca C, Moses EK, Quinn MA, Rice GE.
    Gynecol Oncol; 2000 Nov; 79(2):244-50. PubMed ID: 11063652
    [Abstract] [Full Text] [Related]

  • 8. Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues.
    Umeda T, Eguchi Y, Okino K, Kodama M, Hattori T.
    J Pathol; 1997 Dec; 183(4):388-97. PubMed ID: 9496254
    [Abstract] [Full Text] [Related]

  • 9. Localization and distribution of tissue type and urokinase type plasminogen activators and their inhibitors Type 1 and 2 in human and rhesus monkey fetal membranes.
    Liu YX, Hu ZY, Liu K, Byrne S, Zou RJ, Ny T, d'Lacey C, Ockleford CD.
    Placenta; 1998 Dec; 19(2-3):171-80. PubMed ID: 9548184
    [Abstract] [Full Text] [Related]

  • 10. The urokinase plasminogen activator (uPA) system in uterine natural killer cells in the placental bed during early pregnancy.
    Naruse K, Lash GE, Bulmer JN, Innes BA, Otun HA, Searle RF, Robson SC.
    Placenta; 2009 May; 30(5):398-404. PubMed ID: 19272641
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH, Martin TJ.
    J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
    [Abstract] [Full Text] [Related]

  • 12. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
    Nishida Y, Hayashi Y, Imai Y, Itoh H.
    Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
    [Abstract] [Full Text] [Related]

  • 13. Localization and significance of urokinase plasminogen activator and its receptor in placental tissue from intrauterine, ectopic and molar pregnancies.
    Floridon C, Nielsen O, Holund B, Sunde L, Westergaard JG, Thomsen SG, Teisner B.
    Placenta; 1999 Nov; 20(8):711-21. PubMed ID: 10527826
    [Abstract] [Full Text] [Related]

  • 14. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A, Brun P, Sartori MT, Cortivo R, Dedominicis C, Saggiorato G, Abatangelo G, Secchi AG.
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [Abstract] [Full Text] [Related]

  • 15. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
    Kenichi M, Masanobu M, Takehiko K, Shoko T, Akira F, Katsushige A, Takashi H, Yoshiyuki O, Shigeru K.
    J Lab Clin Med; 2004 Aug; 144(2):69-77. PubMed ID: 15322501
    [Abstract] [Full Text] [Related]

  • 16. Does plasminogen activator inhibitor-1 (PAI-1) control trophoblast invasion? A study of fetal and maternal tissue in intrauterine, tubal and molar pregnancies.
    Floridon C, Nielsen O, Hølund B, Sweep F, Sunde L, Thomsen SG, Teisner B.
    Placenta; 2000 Nov; 21(8):754-62. PubMed ID: 11095924
    [Abstract] [Full Text] [Related]

  • 17. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC, Holzscheiter L, Kotzsch M, Luther T, Kiechle-Bahat M, Sweep FC, Span PN, Schmitt M, Magdolen V.
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [Abstract] [Full Text] [Related]

  • 18. Plasminogen activator inhibitor-1 is an immediate early response gene in regenerating rat liver.
    Thornton AJ, Bruzdzinski CJ, Raper SE, Gelehrter TD.
    Cancer Res; 1994 Mar 01; 54(5):1337-43. PubMed ID: 8118825
    [Abstract] [Full Text] [Related]

  • 19. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.
    Ohba K, Miyata Y, Kanda S, Koga S, Hayashi T, Kanetake H.
    J Urol; 2005 Aug 01; 174(2):461-5. PubMed ID: 16006865
    [Abstract] [Full Text] [Related]

  • 20. Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer.
    Castelló R, Landete JM, España F, Vázquez C, Fuster C, Almenar SM, Ramón LA, Radtke KP, Estellés A.
    Thromb Res; 2007 Aug 01; 120(5):753-62. PubMed ID: 17258797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.